DnaNudge, Mylab Discovery Solutions Forge Dx Partnership for Diabetic Foot Infections
The partners plan to deliver molecular diagnostics to guide treatment of diabetic foot infections for the Indian market.
DxGen, Precision Diabetes Partner on Point-of-Care Analyzer
The test menu for DxGen's Epithod AutoDx includes assays for hemoglobin A1C, C-reactive protein, and urinary albumin assays, with more tests planned for the near future.
LumiraDx Obtains CE Mark for Point-of-Care HbA1c Test
The assay is used to monitor individuals with diabetes and aid in the screening and identification of patients who may be at risk for developing the condition.
FDA Issues Clearances in April to Zeus Scientific, BioMérieux, Roche, Abbott, Others
Zeus Scientific obtained clearance for a test to detect IgG anti-nuclear antibodies and diagnose systemic rheumatic diseases such as systemic lupus erythematosus.
The researchers used mass spec and data analytics to develop lipid profiles that predicted diabetes and cardiovascular disease risk in the distant future.